NfL levels of the two controls increased above average by >10 pg/ml (from 11.3 to 22.5 pg/ml and from 22.9 to 35.4 pg/ml), while sNfL from the MS patient on DMF remained stable (from 6.1 to 5.1 pg/ml). Here, NEFL is linked to myeloid sarcoma.